# RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study

> **NCT02295566** · PHASE2 · COMPLETED · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 12 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Nitric Oxide
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT02295566
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-12
- **Final completion:** 2013-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02295566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02295566, "RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02295566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*